论文信息 - Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease - 字舞流文

Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease

M. Belvisi | S. Nemes | C. Keen | M. W. Sadiq | J. Mäenpää | R. Fuhr | R. Fransson | S. Asimus | M. Hashemi | J. Jonsson | J. Betts | W. Brailsford | T. Körnicke | C. Kristensson | A. Hagberg | S. Necander | T. Jellesmark Jensen | Sara Asimus | Cecilia Kristensson